You searched for Antibody candidate - Page 24 of 69

Best in Biotech 3 May 2016

Here are 12 Biotechs you need to know in Copenhagen – Skål!

…in the Danish capital? As usual, the list is in no particular order. Founded in 1999, Genmab is developing antibody therapies for cancer and is now the biggest European Biotech….

May 3, 2016 - 6 minutesmins - By Denise Neves Gameiro

News and Trends 22 Jun 2020

Swedish Biotech’s Psoriasis Drug Beats Placebo in Phase II

…the market such as Humira and Cosentyx, these antibody drugs aren’t well suited to subcutaneous injections because they can’t penetrate subcutaneous tissue well. Affibody’s psoriasis candidate is a protein drug…

June 22, 2020 - 3 minutesmins - By David Wilson

bicycle therapeutics solid tumors trial 1

News and Trends 14 Feb 2018

Bicycle’s First Peptide-Toxin Conjugate Enters the Clinic for Solid Tumors

…has dosed the first patient in a Phase I/IIa trial with its solid tumors candidate, BT1718. The study will test the drug’s safety and efficacy in around 120 patients with…

February 14, 2018 - 3 minutesmins - By Alex Dale

In Depth 28 Jul 2022

How can vaccines keep up with evolving Covid-19 variants?

…the spike antigen becomes. This makes the key target of the antibody response more subject to mutations,” said Alexandre Le Vert, executive chairman and co-founder of the French vaccine firm…

July 28, 2022 - 7 minutesmins - By Jonathan Smith

News and Trends 7 May 2019

Belgian Biotech Raises €30M Series A to Unlock Undruggable Targets

…led by the VCs BioGeneration Ventures and Wellington Partners, and joined by several other private and public investors. With the money, Confo Therapeutics aims to test its first drug candidate…

May 7, 2019 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 27 Nov 2018

Berlin Biotech Raises €24M to Progress Septic Shock Candidate to Clinic

Adrenomed closed a €24M Series D round to fund further development of its antibody drug that treats septic shock by preventing excessive fluid loss and preserving the blood vessel walls….

November 27, 2018 - 3 minutesmins - By Helen Albert

In Depth 21 Nov 2024

Huntington’s disease: a therapeutic field on a bumpy ride

…in 2022 upon demanding more dosage data. Prilenia’s Huntington’s candidate pridopidine accepted for EMA review Meanwhile, Dutch biotech Prilenia Therapeutics’ Huntington’s candidate is en route to approval. Two weeks ago,…

November 21, 2024 - 9 minutesmins - By Roohi Mariam Peter

News and Trends 11 Oct 2022

License granted to EnteroBiotix for manufacture of microbiome product candidates

Microbiome therapeutics company, EnteroBiotix Limited has been granted a manufacturer’s license for a GMP manufacturing facility for Investigational Medicinal Products (IMP) to make microbiome product candidates for clinical trials. It…

October 11, 2022 - 2 minutesmins - By Liza Laws

News and Trends 5 Oct 2022

FDA fast tracks Immutep non-small cell lung cancer candidate

…first line non-small cell lung cancer (NSCLC). Efti is the company’s first-in-class soluble LAG-3 clinical stage candidate, which activates antigen presenting cells (APC) to engage both the innate and adaptive…

October 5, 2022 - 3 minutesmins - By Jim Cornall

Best in Biotech 14 May 2024

Six biotechs in Belgium making leaps in the clinic

…antibody treatments for fibrosis using technology licensed from the Dutch biotech company ArgenX. Fibrosis is a condition that can damage a number of organs, including the lungs, liver, kidneys, and…

May 14, 2024 - 8 minutesmins - By Roohi Mariam Peter

Opinion 29 Nov 2023

Redefining drug development: the trailblazing evolution of the pharmaceutical industry

…after drug candidates are rigorously optimized at the preclinical stage. However, nine out of ten drug candidates would fail during phase 1, 2, 3 clinical trials and drug approval. It…

November 29, 2023 - 9 minutesmins - By External Contributor

News and Trends 20 Oct 2022

Alvotech and JAMP Pharma add two biosimilar candidates for Canadian market

Alvotech and the JAMP Pharma Group have expanded their exclusive partnership to commercialize biosimilars developed and manufactured by Alvotech. The companies have added two biosimilar candidates from Alvotech’s pipeline: AVT16,…

October 20, 2022 - 2 minutesmins - By Jim Cornall

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

Here are 12 Biotechs you need to know in Copenhagen – Skål!

Swedish Biotech’s Psoriasis Drug Beats Placebo in Phase II

Bicycle’s First Peptide-Toxin Conjugate Enters the Clinic for Solid Tumors

How can vaccines keep up with evolving Covid-19 variants?

Belgian Biotech Raises €30M Series A to Unlock Undruggable Targets

Berlin Biotech Raises €24M to Progress Septic Shock Candidate to Clinic

Huntington’s disease: a therapeutic field on a bumpy ride

License granted to EnteroBiotix for manufacture of microbiome product candidates

FDA fast tracks Immutep non-small cell lung cancer candidate

Six biotechs in Belgium making leaps in the clinic

Redefining drug development: the trailblazing evolution of the pharmaceutical industry

Alvotech and JAMP Pharma add two biosimilar candidates for Canadian market

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!